OptimizeRx Ranked Number 432 Fastest-Growing Company in North America on Deloitte’s 2020 Technology Fast 500™
18 Novembre 2020 - 1:31PM
OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital
health solutions for life science companies, has ranked 432 on
Deloitte’s Technology Fast 500™, a ranking of the 500
fastest-growing technology, media, telecommunications, life
sciences and energy tech companies in North America. OptimizeRx
grew revenue 217% from 2016 to 2019.
OptimizeRx CEO William Febbo credits the company’s innovative
digital health solutions, expanding client base and dedicated team
with the company’s 217% revenue growth. He stated: "It is an honor
to be recognized by Deloitte as one of the nation’s fastest growing
companies. Our team has worked tirelessly and vigorously to get the
company to where it is today. The company’s strong growth is a
testament to our mission in providing quality, affordable
healthcare solutions to both patients and physicians, especially in
this post COVID world. We are positioned very well to capitalize on
our near-term growth opportunities as we continue to provide
long-term value for our shareholders.”
Paul Silverglate, vice chairman, Deloitte LLP and U.S.
technology sector leader, commented: “For more than 25 years, we’ve
been honoring companies that define the cutting edge and this
year’s Technology Fast 500 list is proof positive that technology —
from software and digital media platforms, to biotech — truly does
permeate so many facets of our lives. We congratulate this year’s
winners, especially during a time when innovation is needed more
than ever to address the monumental challenges posed by the
pandemic.”
“Each year the Technology Fast 500 listing validates how
important technology innovation is to our daily lives. It was
interesting to see this year that while software companies
continued to dominate, biotech companies rose to the top of the
winners list for the first time, demonstrating that new categories
of innovation are accelerating in the pursuit of making life
easier, safer and more productive,” said Mohana Dissanayake,
partner, Deloitte & Touche LLP, and industry leader for
technology, media and telecommunications, within Deloitte’s audit
and assurance practice. “We extend sincere congratulations to these
well-deserved winners — who all embody a spirit of curiosity, and a
never-ending commitment to making technology advancements
possible.”
OptimizeRx recently reported that its revenue for the third
quarter of 2020 increased 110% to a record $10.5 million versus the
same year-ago quarter. The result keeps the company on track for
another year of record growth in an expanding addressable
market.
About Deloitte’s 2020
Technology Fast 500™Now in its 26th year,
Deloitte’s Technology Fast 500 provides a ranking of the
fastest-growing technology, media, telecommunications, life
sciences and energy tech companies — both public and private — in
North America. Technology Fast 500 award winners are selected based
on percentage fiscal year revenue growth from 2016 to 2019.
In order to be eligible for Technology Fast 500 recognition,
companies must own proprietary intellectual property or technology
that is sold to customers in products that contribute to a majority
of the company’s operating revenues. Companies must have base-year
operating revenues of at least $US50,000, and current-year
operating revenues of at least $US5 million. Additionally,
companies must be in business for a minimum of four years and be
headquartered within North America.
About DeloitteDeloitte refers to one or more of
Deloitte Touche Tohmatsu Limited, a UK private company limited by
guarantee (“DTTL”), its network of member firms, and their related
entities. DTTL and each of its member firms are legally separate
and independent entities. DTTL (also referred to as “Deloitte
Global”) does not provide services to clients. In the United
States, Deloitte refers to one or more of the US member firms of
DTTL, their related entities that operate using the “Deloitte” name
in the United States and their respective affiliates. Certain
services may not be available to attest clients under the rules and
regulations of public accounting. Please see
www.deloitte.com/about to learn more about our global network
of member firms.
About OptimizeRxOptimizeRx is a
digital health company that provides communications solutions for
life science companies, physicians and patients. Connecting over
half of healthcare providers in the U.S. and millions of
patients through a proprietary network,
the OptimizeRx digital health platform helps patients
afford and stay on medications. The platform unlocks new patient
and physician touchpoints for life science companies along the
patient journey, from point-of-care, to retail pharmacy, through
mobile patient engagement.
For more information, follow the company
on Twitter, LinkedIn or
visit www.optimizerx.com.
OptimizeRx Contact Doug Baker, CFOTel
(248) 651-6568
(x807)dbaker@optimizerx.com
Media Contact Maira Alejandra, Media Relations
ManagerTel (754) 245-7070 malejandra@optimizerx.com
Investor Relations Contact Ron Both,
CMA Tel (949) 432-7557 oprx@cma.team
Grafico Azioni OptimizeRx (NASDAQ:OPRX)
Storico
Da Giu 2024 a Lug 2024
Grafico Azioni OptimizeRx (NASDAQ:OPRX)
Storico
Da Lug 2023 a Lug 2024